A Dose Ranging Vehicle Controlled Study to Determine the Safety and Efficacy of Permethrin Foam, 5% and Permethrin Foam, 4% for the Treatment of Scabies

Inclusion Criteria: * Clinical diagnosis of active scabies infection. * Subject is in good general health with normal appearing skin in noninfested areas. * Females must be post-menopausal, surgically sterile or use an effective method of birth control with a negative pregnancy test (10 years of age and older) at study start. Exclusion Criteria: * Subject is pregnant, lactating, or is planning to become pregnant during the study. * Subject has used any ectoparasiticide within the three weeks prior to study start. * Subject has signs of systemic infection or is receiving systemic therapy for an infectious disease. * Subject has severe cutaneous bacterial or fungal infections requiring therapy or heavily crusted lesions consistent with Norwegian scabies. * Subject is currently enrolled in an investigational drug or device study or has used an investigational drug or device within 30 days prior to study start. * Subject whose close personal contacts will not comply with standard of care for fomite management.